CMG Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Cash & Equivalents	6,123	2,588	1,243	4,456	18,571
Short-Term Investments	20,379	74,206	67,585	73,357	39,000
Trading Asset Securities	-	-	-	-	62,003
Cash & Short-Term Investments	26,502	76,794	68,827	77,813	119,574
Cash Growth	-65.49%	11.58%	-11.55%	-34.92%	119.54%
Accounts Receivable	34,715	31,312	23,320	21,330	20,291
Other Receivables	637.15	1,174	929.56	1,143	869.89
Receivables	35,360	32,486	24,250	34,542	21,161
Inventory	29,542	23,788	20,570	21,270	9,049
Prepaid Expenses	2,752	141.95	150.35	143.3	71.04
Other Current Assets	1,022	1,649	1,940	1,301	729.16
Total Current Assets	95,179	134,859	115,737	135,070	150,584
Property, Plant & Equipment	114,994	77,977	50,711	37,472	24,119
Long-Term Investments	55,525	46,463	52,565	22,996	4,003
Goodwill	2,274	2,274	2,274	-	-
Other Intangible Assets	3,437	2,908	3,675	3,105	1,339
Long-Term Deferred Tax Assets	5,508	3,315	2,973	2,603	2,006
Long-Term Deferred Charges	12,761	16,372	13,627	11,282	9,736
Other Long-Term Assets	477.9	291.94	456.59	621.92	455.44
Total Assets	305,962	303,437	242,098	213,260	192,243
Accounts Payable	9,581	12,013	9,197	11,245	4,328
Accrued Expenses	1,826	3,198	3,204	2,917	2,054
Short-Term Debt	46,721	44,068	880	-	-
Current Portion of Long-Term Debt	25,000	0	-	-	-
Current Portion of Leases	142.68	221.4	206.16	356.41	129.64
Current Income Taxes Payable	161.54	-	-	99.45	-
Other Current Liabilities	20,224	15,145	11,042	7,285	2,794
Total Current Liabilities	103,656	74,645	24,529	21,903	9,306
Long-Term Debt	-	35,436	24,701	6,000	-
Long-Term Leases	144.85	240.26	332.07	356.43	156.76
Pension & Post-Retirement Benefits	467.92	1,091	753.79	-	1,057
Other Long-Term Liabilities	138.05	2,483	1,550	48.38	1,565
Total Liabilities	104,407	113,895	51,866	28,307	12,085
Common Stock	73,921	69,446	69,446	69,446	69,446
Additional Paid-In Capital	122,556	104,889	104,641	104,641	104,812
Retained Earnings	4,644	13,894	14,219	9,000	5,055
Comprehensive Income & Other	433.39	1,313	1,926	1,866	845.23
Shareholders' Equity	201,555	189,542	190,233	184,953	180,158
Total Liabilities & Equity	305,962	303,437	242,098	213,260	192,243
Total Debt	72,008	79,965	26,119	6,713	286.39
Net Cash (Debt)	-45,506	-3,171	42,708	71,100	119,288
Net Cash Growth	-	-	-39.93%	-40.40%	119.02%
Net Cash Per Share	-316.10	-5.88	307.49	511.91	981.40
Filing Date Shares Outstanding	146.8	138.89	138.89	138.89	138.89
Total Common Shares Outstanding	146.8	138.89	138.89	138.89	138.89
Working Capital	-8,477	60,214	91,208	113,167	141,278
Book Value Per Share	1373.03	1364.67	1369.64	1331.63	1297.11
Tangible Book Value	195,844	184,360	184,284	181,848	178,820
Tangible Book Value Per Share	1334.13	1327.36	1326.81	1309.28	1287.47
Land	19,575	19,574	3,985	2,709	2,709
Buildings	12,680	12,312	11,004	10,741	10,741
Machinery	18,937	19,592	18,421	16,934	14,678
Construction In Progress	82,466	44,617	34,094	22,579	7,511

Source: S&P Global Market Intelligence. Standard template. Financial Sources.